Clinical Trials

Clinical Trials for Retinal Conditions

Retinal Consultants of Arizona’s Retinal Research Institute consistently enrolls patients with the following diagnoses for new studies and clinical trials.

Wet AMD (treated and untreated)
Dry AMD (Geographic Atrophy)
Diabetic Macular Edema
Retinal Vein Occlusion

Enrolling Studies

Treatment Naive and Previously Treated Wet AMD
RegenxBio – RGX-3142202
Diabetic Retinopathy with and without DME
SOL-R and Lugano
RGX Ascent / Atmosphere/ AAviate
RGX Altitude
Oculis DME

Upcoming Studies

Regeneron GA – Subcutaneous monthly injection of anti-complement agent
Astellas GA- Phase 4 observational study of patients receiving Izervay treatment
Genentech DME Tiež activator in combo with Aflibercept/Farcimab
Advarum Wet AMD Intravitreal injection of genetherapy coding for Aflibercep

Interested in participating in clinical research studies? Contact our research team at 602-222-2221.

Our Patients’ Experiences

“They have an effective system,I was treated courteously,and kept notified when and where to proceed for each Stage of the visit”

Fred G.

“Very friendly staff and the Doctor was friendly and told me what I needed to know. Very thorough. Thanks for taking care of my eyes and your commitment to helping your patients.”

Margaret H.

“Outstanding practice of phenomenal doctors. I was very anxious about my eye issue, but Dr. Mehta with his confident relaxed manner put my fears to rest. Excellent communication with patients-and competent staff is why I give Retinal Consultants of Arizona my highest recommendation.”

Janine K.

Previous Next

What is the Screening Process?

The screening process helps us determine if you’re a candidate for a given study. All studies have entry criteria that are designed to ensure your safety and that data produced is useful.

Learn More

What to Expect

Depending on the clinical trial, you will most likely have several visits throughout the period of the research study. Learn about what to expect once you are enrolled.

Learn More

Interested in Clinical Trials?

Learn more about our Retinal Research Institute or give us a call with any questions related to our studies and trials.

(602) 222-2221

About the Institute